ArticleCancer discovery2017

Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

Michael R McKeown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.